Nwam LLC Illumina, Inc. Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Nwam LLC holds 5,262 shares of ILMN stock, worth $715,737. This represents 0.04% of its overall portfolio holdings.

Number of Shares

5,262

Previous 5,258 0.08%

Holding current value

$715,737

Previous $548,000 25.18%

% of portfolio

0.04%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$105.28 - $135.9 $421 - $543	4 Added 0.08%	5,262 $686,000
Q2 2024 Jul 23, 2024	SELL	$101.05 - $133.57 $2,425 - $3,205	-24 Reduced 0.45%	5,258 $548,000
Q1 2024 May 09, 2024	SELL	$127.73 - $147.2 $1,405 - $1,619	-11 Reduced 0.21%	5,282 $725,000
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $55,859 - $85,803	-602 Reduced 10.21%	5,293 $736,000
Q3 2023 Oct 31, 2023	SELL	$128.91 - $192.44 $3,738 - $5,580	-29 Reduced 0.49%	5,895 $809,000
Q2 2023 Aug 09, 2023	BUY	$183.43 - $232.67 $3,485 - $4,420	19 Added 0.32%	5,924 $1.11 Million
Q1 2023 May 12, 2023	SELL	$193.75 - $232.55 $8,331 - $9,999	-43 Reduced 0.72%	5,905 $1.37 Million
Q4 2022 Feb 07, 2023	BUY	$187.24 - $242.74 $1,685 - $2,184	9 Added 0.15%	5,948 $1.2 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $41,294 - $52,993	233 Added 4.08%	5,939 $1.13 Million
Q2 2022 Aug 10, 2022	SELL	$181.58 - $368.0 $135,821 - $275,264	-748 Reduced 11.59%	5,706 $1.1 Million
Q4 2021 Feb 10, 2022	BUY	$347.28 - $421.83 $1.61 Million - $1.95 Million	4,629 Added 253.64%	6,454 $2.46 Million
Q3 2021 Nov 03, 2021	BUY	$405.61 - $524.84 $740,238 - $957,833	1,825 New	1,825 $740,000

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.4B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account